2022-500879-31-00CompletedPhase 1
Individualization of dosage regimens in obese patients: application to acyclovir
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Mar 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 15 Jun 2022
- Start date
- 9 Apr 2024
- Lead sponsor
- Centre Hospitalier Universitaire De Toulouse
- Diseases
- Obesity
- EU CT number
- 2022-500879-31-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire de Toulouse | Toulouse | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.